Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Journal of Neuropathology and Experimental Neurology
|
February 8, 2006
OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas
Talitha de Haas, Esmeralda Oussoren, Wieslawa Grajkowska, et al.
Brain Pathology (Zurich, Switzerland)
|
November 17, 2009
Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors
Karin Boer, Peter B Crino, Jan A Gorter, et al.
Immunology
|
August 21, 2010
Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma
Nadia A Atai, Manju Bansal, Cheungh Lo, et al.
Human Mutation
|
January 2, 2009
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors
Fonnet E Bleeker, Simona Lamba, Sieger Leenstra, et al.
Cancer Letters
|
May 29, 2009
Angiogenesis inhibitor DC101 delays growth of intracerebral glioblastoma but induces morbidity when combined with irradiation
Joost J C Verhoeff, Lukas J A Stalpers, Cornelis J F Van Noorden, et al.
Epilepsia
|
August 16, 2003
Overexpression of the human major vault protein in gangliogliomas
Eleonora Aronica, Jan A Gorter, Erwin A van Vliet, et al.
Cell Death and Differentiation
|
June 17, 2017
The ALS-linked E102Q mutation in Sigma receptor-1 leads to ER stress-mediated defects in protein homeostasis and dysregulation of RNA-binding proteins
Alice Dreser, Jan Tilmann Vollrath, Antonio Sechi, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
April 30, 2011
Differential activity of NADPH-producing dehydrogenases renders rodents unsuitable models to study IDH1R132 mutation effects in human glioblastoma
Nadia A Atai, Nynke A Renkema-Mills, Joost Bosman, et al.
Plos One
|
September 5, 2008
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features
Marcel Kool, Jan Koster, Jens Bunt, et al.
Neuro-Oncology
|
February 11, 2014
The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone
Remco J Molenaar, Dagmar Verbaan, Simona Lamba, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Journal of Neuropathology and Experimental Neurology
|
February 8, 2006
OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas
Talitha de Haas, Esmeralda Oussoren, Wieslawa Grajkowska, et al.
Brain Pathology (Zurich, Switzerland)
|
November 17, 2009
Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors
Karin Boer, Peter B Crino, Jan A Gorter, et al.
Immunology
|
August 21, 2010
Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma
Nadia A Atai, Manju Bansal, Cheungh Lo, et al.
Human Mutation
|
January 2, 2009
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors
Fonnet E Bleeker, Simona Lamba, Sieger Leenstra, et al.
Cancer Letters
|
May 29, 2009
Angiogenesis inhibitor DC101 delays growth of intracerebral glioblastoma but induces morbidity when combined with irradiation
Joost J C Verhoeff, Lukas J A Stalpers, Cornelis J F Van Noorden, et al.
Epilepsia
|
August 16, 2003
Overexpression of the human major vault protein in gangliogliomas
Eleonora Aronica, Jan A Gorter, Erwin A van Vliet, et al.
Cell Death and Differentiation
|
June 17, 2017
The ALS-linked E102Q mutation in Sigma receptor-1 leads to ER stress-mediated defects in protein homeostasis and dysregulation of RNA-binding proteins
Alice Dreser, Jan Tilmann Vollrath, Antonio Sechi, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
April 30, 2011
Differential activity of NADPH-producing dehydrogenases renders rodents unsuitable models to study IDH1R132 mutation effects in human glioblastoma
Nadia A Atai, Nynke A Renkema-Mills, Joost Bosman, et al.
Plos One
|
September 5, 2008
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features
Marcel Kool, Jan Koster, Jens Bunt, et al.
Neuro-Oncology
|
February 11, 2014
The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone
Remco J Molenaar, Dagmar Verbaan, Simona Lamba, et al.
Page
of 7